Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2022-08-25 00:00:00 ET · period of report 2022-08-24 · accession 0001437749-22-021331 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-25 | 2022-08-24 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $1.72 | +5,005 | 70.5K | +8% | +$8,584 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-24 | P | A | 2,406 | $1.71 | 67,924 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |
| 2 | Common | Common Stock | 2022-08-24 | P | A | 18 | $1.70 | 65,518 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |
| 3 | Common | Common Stock | 2022-08-24 | P | A | 2,581 | $1.72 | 70,505 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |